Vitalhub Corp. (TSE:VHI - Get Free Report) has earned an average rating of "Buy" from the seven analysts that are currently covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is C$13.25.
Several brokerages have recently weighed in on VHI. Raymond James Financial upped their target price on Vitalhub from C$13.50 to C$14.00 and gave the stock an "outperform" rating in a research note on Friday, June 20th. National Bankshares set a C$14.00 target price on Vitalhub and gave the stock an "outperform" rating in a research note on Tuesday, June 10th. National Bank Financial raised Vitalhub to a "strong-buy" rating in a research note on Monday, June 9th. TD Securities upped their target price on Vitalhub from C$13.00 to C$14.00 and gave the stock a "buy" rating in a research note on Monday, March 31st. Finally, Scotiabank upped their target price on Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research note on Friday, June 20th.
Get Our Latest Stock Analysis on Vitalhub
Insider Buying and Selling
In other news, Director Francis Nelson Shen acquired 25,000 shares of Vitalhub stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of C$10.23 per share, with a total value of C$255,750.00. Corporate insiders own 18.57% of the company's stock.
Vitalhub Price Performance
Shares of VHI stock opened at C$10.76 on Friday. The company has a market cap of C$582.03 million, a price-to-earnings ratio of 175.01, a PEG ratio of 1.18 and a beta of 1.26. The stock has a 50 day simple moving average of C$10.77 and a 200-day simple moving average of C$10.58. Vitalhub has a 1-year low of C$6.74 and a 1-year high of C$12.34.
Vitalhub Company Profile
(
Get Free ReportVitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.